ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MYL Stock Price » MYL Stock News

Mylan Inc. Share News

 Mylan Inc. (mm) Stock Price
MYL Stock Price
 Mylan Inc. (mm) Stock Chart
MYL Stock Chart
 Mylan Inc. (mm) Stock News
MYL Stock News
 Mylan Inc. (mm) Company Information
MYL Company Information
 Mylan Inc. (mm) Stock Trades
MYL Stock Trades

Mylan Confirms Endo Suit Over Generic Migraine Drug Application

DOW JONES NEWSWIRES Mylan Inc. (MYL) confirmed Wednesday that it has been sued by Endo Pharmaceuticals Holdings Inc. (ENDP) over its application for approval of a generic drug used to treat acute migraine headaches in adults. Mylan--one of the world's largest generic drug makers--said it believes it is the first company to file a substantially complete application for approval of frovatriptan succinate EQ, a generic version of Frova. The company said it expects to qualify for 180 days of marketing exclusivity upon final approval from the Food and Drug Administration. Mylan, which has had litigation-related charges figure prominently in its recent quarterly results, last month reported second-quarter earnings surged 70% as sales got a lift from a weaker dollar. Shares closed Tuesday at $20.01 and were inactive in recent premarket trade. Through the latest close, the stock is down 5.3% since the start of the year. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Mylan Inc. (MYL)
DateTimeHeadline
08/07/201417:06:48U.S. Stock Slide; Dow Industrials Fall to Lowest Since April
08/07/201409:55:10MARKET SNAPSHOT: U.S. Stocks Open Higher: 21st Century Fox Rallies
08/07/201409:43:14U.S. Hot Stocks: Hot Stocks to Watch
08/07/201409:14:06MARKET SNAPSHOT: U.S. Stocks: Futures Higher; Jobless Claims...
08/07/201408:19:02MARKET SNAPSHOT: U.S. Stocks: Futures Inch Up; ECB News Conference...
08/07/201408:12:09MARKET SNAPSHOT: U.S. Stocks: Futures Inch Up With ECB Presser...
08/07/201406:22:55MARKET SNAPSHOT: U.S. Stocks: Futures Up Ahead Of ECB, Jobless...
08/01/201411:49:10RoundTable Plans to Sell CorePharma for at Least $1 Billion
07/14/201418:35:14MARKET SNAPSHOT: U.S. Stocks: Dow Closes Above 17,000
07/14/201418:30:00MARKET SNAPSHOT: U.S. Stocks Rise On Earnings, M&A News
07/14/201418:24:15MARKET SNAPSHOT: U.S. Stocks: Dow Tops 17,000, Eyes Record Close
07/14/201418:23:23MARKET SNAPSHOT: U.S. Stocks: Dow Tops 17,000 Again As Citi Rallies
07/14/201418:23:10MARKET SNAPSHOT: U.S. Stocks: Dow Tops 17,0000 Again As Citi...
07/14/201418:21:57Abbott Flees Struggling Business to Explore New Deals -- Market...
07/14/201418:20:11MARKET SNAPSHOT: U.S. Stocks: Futures Climb; Citigroup Results...
05/15/201408:21:52Mylan Applauds Court's Dismissal of Teva's Suit Against FDA
04/28/201416:56:41EUROPE MARKETS: European Shares Up; AstraZeneca Surges On M&A...
04/28/201416:34:51EUROPE MARKETS: European Shares Up; AstraZeneca Surges On M&A...
04/28/201410:03:44Meda Rejects Mylan Merger Bid
04/25/201411:50:05Mylan Reportedly Makes Bid for Meda

Mylan Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad